LIT-927
≥98%
- Product Code: 101245
CAS:
2172879-52-4
| Molecular Weight: | 328.75 g./mol | Molecular Formula: | C₁₇H₁₃ClN₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
LIT-927 is primarily researched for its potential therapeutic applications, particularly in the field of inflammation and pain management. It acts as a selective antagonist for the GPR55 receptor, which is implicated in various physiological processes, including inflammatory responses and nociception. Studies suggest that LIT-927 could be effective in alleviating chronic pain conditions, such as neuropathic pain, by modulating the GPR55 signaling pathway. Additionally, its anti-inflammatory properties make it a candidate for treating inflammatory diseases, including arthritis and other autoimmune disorders. Research is ongoing to explore its efficacy and safety in preclinical models, with the aim of developing it as a novel therapeutic agent.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Yellow To Orange To Brown Powder |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿7,900.00 |
+
-
|
| 0.010 | 10-20 days | ฿13,500.00 |
+
-
|
| 0.050 | 10-20 days | ฿31,580.00 |
+
-
|
LIT-927
LIT-927 is primarily researched for its potential therapeutic applications, particularly in the field of inflammation and pain management. It acts as a selective antagonist for the GPR55 receptor, which is implicated in various physiological processes, including inflammatory responses and nociception. Studies suggest that LIT-927 could be effective in alleviating chronic pain conditions, such as neuropathic pain, by modulating the GPR55 signaling pathway. Additionally, its anti-inflammatory properties make it a candidate for treating inflammatory diseases, including arthritis and other autoimmune disorders. Research is ongoing to explore its efficacy and safety in preclinical models, with the aim of developing it as a novel therapeutic agent.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :